Evotec OAI and Roche, BioImage, The Strategic Research Institute s Drug Discovery and Development Outsourcing Conference, and Discovery Partners | GenomeWeb

Evotec, Roche Ink Drug Discovery Deal

Evotec OAI has entered into a "worldwide discovery chemistry agreement" with Roche, the companies announced on May 12.

This is the fourth chemistry alliance between the two companies since the first one was struck in 2001, when Evotec began supporting Roche at four sites in the design and synthesis of chemical compounds, which Roche added to its compound library for drug screening, the companies said.

In 2003, the companies said they expanded the partnership to encompass medicinal chemistry.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.